Overexpression of AMP-metabolizing enzymes controls adenine nucleotide levels and AMPK activation in HEK293T cells

FASEB Journal

Volumn 26, Issue 6, 2012, Pages 2685-2694

  Plaideau, Catheline ^a   Liu, Jianming ^b   Hartleib Geschwindner, Judith ^b   Bastin Coyette, Laurent ^a   Bontemps, Françoise ^a   Oscarsson, Jan ^b   Hue, Louis ^a   Rider, Mark H ^a  

^a DE DUVE INSTITUTE   (Belgium)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

Adenylate energy charge; cN 1A; Control coefficient

Indexed keywords

ADENINE NUCLEOTIDE; ADENOSINE MONOPHOSPHATE DEAMINASE; ADENOSINE PHOSPHATE; MITOGEN ACTIVATED PROTEIN KINASE; OLIGOMYCIN; PLASMID VECTOR;

ARTICLE; CELL STRAIN HEK293; CONCENTRATION (PARAMETERS); EMBRYO; ENERGY METABOLISM; ENZYME ACTIVATION; ENZYME METABOLISM; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; PRIORITY JOURNAL;

5'-NUCLEOTIDASE; ADENINE NUCLEOTIDES; ADENOSINE MONOPHOSPHATE; AMP DEAMINASE; AMP-ACTIVATED PROTEIN KINASES; ENZYME ACTIVATION; HEK293 CELLS; HUMANS; KINETICS; OLIGOMYCINS;

EID: 84861786439     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.11-198168     Document Type: Article

References (58)

1. Steinberg, G. R., and Kemp, B. E. (2009) AMPK in health and disease. Physiol. Rev. 89, 1025-1078
2. Hardie, D. G., Carling, D., and Carlson, M. (1998) The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu. Rev. Biochem. 67, 821-855 (Pubitemid 28411146)
3. Kahn, B. B., Alquier, T., Carling, D., and Hardie, D. G. (2005) AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 1, 15-25 (Pubitemid 43960587)
4. Witters, L. A., Kemp, B. E., and Means, A. R. (2006) Chutes and ladders: the search for protein kinases that act on AMPK. Trends Biochem. Sci. 31, 13-16 (Pubitemid 43117536)
5. Richter, E. A., and Ruderman, N. B. (2009) AMPK and the biochemistry of exercise: implications for human health and disease. Biochem. J. 418, 261-275
6. Davies, S. P., Helps, N. R., Cohen, P. T., and Hardie, D. G. (1995) 5′-AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP-activated protein kinase. Studies using bacterially expressed human protein phosphatase-2Cαand native bovine protein phosphatase-2AC. FEBS Lett. 377, 421-425 (Pubitemid 26027159)
7. Hardie, D. G., Salt, I. P., Hawley, S. A., and Davies, S. P. (1999) AMP-activated protein kinase: an ultrasensitive system for monitoring cellular energy charge. Biochem. J. 338(Part 3), 717-722 (Pubitemid 29140078)
8. Sanders, M. J., Grondin, P. O., Hegarty, B. D., Snowden, M. A., and Carling, D. (2007) Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade. Biochem. J. 403, 139-148 (Pubitemid 46569875)
9. Xiao, B., Sanders, M. J., Underwood, E., Heath, R., Mayer, F. V., Carmena, D., Jing, C., Walker, P. A., Eccleston, J. F., Haire, L. F., Saiu, P., Howell, S. A., Aasland, R., Martin, S. R., Carling, D., and Gamblin, S. J. (2011) Structure of mammalian AMPK and its regulation by ADP. Nature 472, 230-233
10. Oakhill, J. S., Steel, R., Chen, Z. P., Scott, J. W., Ling, N., Tam, S., and Kemp, B. E. (2011) AMPK is a direct adenylate charge-regulated protein kinase. Science 332, 1433-1435
11. Xiao, B., Heath, R., Saiu, P., Leiper, F. C., Leone, P., Jing, C., Walker, P. A., Haire, L., Eccleston, J. F., Davis, C. T., Martin, S. R., Carling, D., and Gamblin, S. J. (2007) Structural basis for AMP binding to mammalian AMP-activated protein kinase. Nature 449, 496-500 (Pubitemid 47509548)
12. Mahnke-Zizelman, D. K., D'Cunha, J., Wojnar, J. M., Brogley, M. A., and Sabina, R. L. (1997) Regulation of rat AMP deaminase 3 (isoform C) by development and skeletal muscle fibre type. Biochem. J. 326(Part 2), 521-529 (Pubitemid 27417232)
13. Mahnke-Zizelman, D. K., Tullson, P. C., and Sabina, R. L. (1998) Novel aspects of tetramer assembly and N-terminal domain structure and function are revealed by recombinant expression of human AMP deaminase isoforms. J. Biol. Chem. 273, 35118-35125 (Pubitemid 29028214)
14. Morisaki, T., Sabina, R. L., and Holmes, E. W. (1990) Adenylate deaminase. A multigene family in humans and rats. J. Biol. Chem. 265, 11482-11486
15. Ogasawara, N., Goto, H., Yamada, Y., and Watanabe, T. (1978) Distribution of AMP-deaminase isozymes in rat tissues. Eur. J. Biochem. 87, 297-304 (Pubitemid 8355171)
16. Ogasawara, N., Goto, H., and Watanabe, T. (1975) Isozymes of rat brain AMP deaminase: developmental changes and characterizations of five forms. FEBS Lett. 58, 245-248
17. Bianchi, V., and Spychala, J. (2003) Mammalian 5′-nucleotidases. J. Biol. Chem. 278, 46195-46198
18. Francis, S. H., Houslay, M. D., and Conti, M. (2011) Phosphodiesterase inhibitors: factors that influence potency, selectivity, and action. Handb. Exp. Pharmacol. 204, 47-84
19. Dale, S., Wilson, W. A., Edelman, A. M., and Hardie, D. G. (1995) Similar substrate recognition motifs for mammalian AMP-activated protein kinase, higher plant HMG-CoA reductase kinase-A, yeast SNF1, and mammalian calmodulin-dependent protein kinase I. FEBS Lett. 361, 191-195
20. Horman, S., Vertommen, D., Heath, R., Neumann, D., Mouton, V., Woods, A., Schlattner, U., Wallimann, T., Carling, D., Hue, L., and Rider, M. H. (2006) Insulin antagonizes ischemia-induced Thr172 phosphorylation of AMP-activated protein kinase α-subunits in heart via hierarchical phosphorylation of Ser485/491. J. Biol. Chem. 281, 5335-5340 (Pubitemid 43847626)
21. Hunsucker, S. A., Spychala, J., and Mitchell, B. S. (2001) Human cytosolic 5′-nucleotidase I: characterization and role in nucleoside analog resistance. J. Biol. Chem. 276, 10498-10504
22. Haas, A. L., and Sabina, R. L. (2003) N-terminal extensions of the human AMPD2 polypeptide influence ATP regulation of isoform L. Biochem. Biophys. Res. Commun. 305, 421-427 (Pubitemid 36555486)
23. Chapman, A. G., and Atkinson, D. E. (1973) Stabilization of adenylate energy charge by the adenylate deaminase reaction. J. Biol. Chem. 248, 8309-8312
24. Belsham, G. J., Denton, R. M., and Tanner, M. J. (1980) Use of a novel rapid preparation of fat-cell plasma membranes employing Percoll to investigate the effects of insulin and adrenaline on membrane protein phosphorylation within intact fat-cells. Biochem. J. 192, 457-467 (Pubitemid 11206821)
25. Woods, A., Salt, I., Scott, J., Hardie, D. G., and Carling, D. (1996) The α1 and α2 isoforms of the AMP-activated protein kinase have similar activities in rat liver but exhibit differences in substrate specificity in vitro. FEBS Lett. 397, 347-351 (Pubitemid 26414047)
26. Marsin, A. S., Bertrand, L., Rider, M. H., Deprez, J., Beauloye, C., Vincent, M. F., Van den Berghe, G., Carling, D., and Hue, L. (2000) Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia. Curr. Biol. 10, 1247-1255
27. Mitchelhill, K. I., Stapleton, D., Gao, G., House, C., Michell, B., Katsis, F., Witters, L. A., and Kemp, B. E. (1994) Mammalian AMP-activated protein kinase shares structural and functional homology with the catalytic domain of yeast Snf1 protein kinase. J. Biol. Chem. 269, 2361-2364 (Pubitemid 24235720)
28. Roskoski, R., Jr. (1983) Assays of protein kinase. Methods Enzymol. 99, 3-6
29. Bontemps, F., Delacauw, A., Cardoen, S., Van Den Neste, E., and Van Den Berghe, G. (2000) Metabolism and cytotoxic effects of 2-chloroadenine, the major catabolite of 2-chloro-2′-deoxyadenosine. Biochem. Pharmacol. 59, 1237-1243 (Pubitemid 30157886)
30. Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254
31. Sitte, H. H., Hiptmair, B., Zwach, J., Pifl, C., Singer, E. A., and Scholze, P. (2001) Quantitative analysis of inward and outward transport rates in cells stably expressing the cloned human serotonin transporter: inconsistencies with the hypothesis of facilitated exchange diffusion. Mol. Pharmacol. 59, 1129-1137 (Pubitemid 32381593)
32. Atkinson, D. E. (1968) The energy charge of the adenylate pool as a regulatory parameter. Interaction with feedback modifiers. Biochemistry 7, 4030-4034
33. Bausch-Jurken, M. T., and Sabina, R. L. (1995) Divergent N-terminal regions in AMP deaminase and isoform-specific catalytic properties of the enzyme. Arch. Biochem. Biophys. 321, 372-380
34. Viollet, B., Foretz, M., Guigas, B., Horman, S., Dentin, R., Bertrand, L., Hue, L., and Andreelli, F. (2006) Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders. J. Physiol. 574, 41-53 (Pubitemid 43905795)
35. Mantovani, J., and Roy, R. (2011) Re-evaluating the general-(ized) roles of AMPK in cellular metabolism. FEBS Lett. 585, 967-972
36. Cabarcas, S. M., Hurt, E. M., and Farrar, W. L. (2010) Defining the molecular nexus of cancer, type 2 diabetes and cardiovascular disease. Curr. Mol. Med. 10, 744-755
37. Jalving, M., Gietema, J. A., Lefrandt, J. D., de Jong, S., Reyners, A. K., Gans, R. O., and de Vries, E. G. (2010) Metformin: taking away the candy for cancer? Eur. J. Cancer 46, 2369-2380
38. Scott, J. W., van Denderen, B. J., Jorgensen, S. B., Honeyman, J. E., Steinberg, G. R., Oakhill, J. S., Iseli, T. J., Koay, A., Gooley, P. R., Stapleton, D., and Kemp, B. E. (2008) Thienopyridone drugs are selective activators of AMP-activated protein kinase β1-containing complexes. Chem. Biol. 15, 1220-1230
39. Hunter, R. W., Treebak, J. T., Wojtaszewski, J. F., and Sakamoto, K. (2011) Molecular mechanism by which AMP-activated protein kinase activation promotes glycogen accumulation in muscle. Diabetes 60, 766-774
40. Saha, A. K., Xu, X. J., Lawson, E., Deoliveira, R., Brandon, A. E., Kraegen, E. W., and Ruderman, N. B. (2010) Downregulation of AMPK accompanies leucine- and glucose-induced increases in protein synthesis and insulin resistance in rat skeletal muscle. Diabetes 59, 2426-2434
41. Lai, Y. C., Zarrinpashneh, E., and Jensen, J. (2010) Additive effect of contraction and insulin on glucose uptake and glycogen synthase in muscle with different glycogen contents. J. Appl. Physiol. 108, 1106-1115
42. McGilvery, R. W., and Murray, T. W. (1974) Calculated equilibria of phosphocreatine and adenosine phosphates during utilization of high energy phosphate by muscle. J. Biol. Chem. 249, 5845-5850
43. Neumann, D., Wallimann, T., Rider, M. H., Tokarska-Schlattner, M., Hardie, D. G., and Schlattner, U. (2007) Signalling by AMP-activated protein kinase. In Molecular System Bioenergetics: Energy for Life (Saks, V. ed) pp. 303-338, Wiley-VCH, Weinheim, Germany
44. Hancock, C. R., Janssen, E., and Terjung, R. L. (2006) Contraction-mediated phosphorylation of AMPK is lower in skeletal muscle of adenylate kinase-deficient mice. J. Appl. Physiol. 100, 406-413 (Pubitemid 43671588)
45. Zhang, S. J., Sandstrom, M. E., Aydin, J., Westerblad, H., Wieringa, B., and Katz, A. (2008) Activation of glucose transport and AMP-activated protein kinase during muscle contraction in adenylate kinase-1 knockout mice. Acta Physiol. (Oxf.) 192, 413-420 (Pubitemid 351208209)
46. Sahlin, K., and Broberg, S. (1990) Adenine nucleotide depletion in human muscle during exercise: causality and significance of AMP deamination. Int. J. Sports Med. 11(Suppl. 2), S62-S67 (Pubitemid 20186073)
47. Tullson, P. C., and Terjung, R. L. (1991) Adenine nucleotide metabolism in contracting skeletal muscle. Exerc. Sport Sci. Rev. 19, 507-537
48. Rundell, K. W., Tullson, P. C., and Terjung, R. L. (1992) Altered kinetics of AMP deaminase by myosin binding. Am. J. Physiol. 263, C294-C299
49. Zeng, C., and Fromm, H. J. (1995) Active site residues of human brain hexokinase as studied by site-specific mutagenesis. J. Biol. Chem. 270, 10509-10513
50. Rush, J. W., Tullson, P. C., and Terjung, R. L. (1998) Molecular and kinetic alterations of muscle AMP deaminase during chronic creatine depletion. Am. J. Physiol. 274, C465-C471
51. Newby, A. C. (1988) The pigeon heart 5′-nucleotidase responsible for ischaemia-induced adenosine formation. Biochem. J. 253, 123-130
52. Ren, J. M., and Hultman, E. (1990) Regulation of phosphorylase a activity in human skeletal muscle. J. Appl. Physiol. 69, 919-923 (Pubitemid 20338692)
53. Halfman, C. J., and Marcus, F. (1982) A method for determining kinetic parameters at high enzyme concentrations. Biochem. J. 203, 339-342
54. Wegener, G. (1996) Flying insects: model systems in exercise physiology. Experientia 52, 404-412
55. Frederich, M., and Balschi, J. A. (2002) The relationship between AMP-activated protein kinase activity and AMP concentration in the isolated perfused rat heart. J. Biol. Chem. 277, 1928-1932 (Pubitemid 34968770)
56. Teijeira, S., San Millan, B., Fernandez, J. M., Rivas, E., Vieitez, I., Miranda, S., Gonzalez, F., and Navarro, C. (2009) Myoadenylate deaminase deficiency: clinico-pathological and molecular study of a series of 27 Spanish cases. Clin. Neuropathol. 28, 136-142
57. Rundell, K. W., Tullson, P. C., and Terjung, R. L. (1992) AMP deaminase binding in contracting rat skeletal muscle. Am. J. Physiol. 263, C287-C293
58. Kulkarni, S. S., Karlsson, H. K., Szekeres, F., Chibalin, A. V., Krook, A., and Zierath, J. R. (2011) Suppression of 5′ nucleotidase enzymes promotes AMPK phosphorylation and metabolism in human and mouse skeletal muscle. J. Biol. Chem. 286, 34567-34574